{
  "queries": [
    {
      "id": "metformin_cancer",
      "query": "Evaluate repurposing opportunities for Metformin (small molecule) in Oncology (cancer)",
      "followups": [
        "Analyze unmet medical needs in Oncology therapy",
        "Assess competitive products and market dynamics for Oncology",
        "Search clinical trial registries for studies of Metformin in Oncology",
        "Review patent landscape focusing on Metformin Oncology",
        "Evaluate global market size and growth projections for Oncology",
        "Identify key companies and therapies in cancer area",
        "Examine manufacturing and API sourcing considerations for Metformin",
        "Monitor recent scientific publications on Metformin and Oncology",
        "Check regulatory status and approvals of Metformin in new indication",
        "Draft strategic recommendations for repurposing Metformin into Oncology"
      ]
    },
    {
      "id": "sildenafil_altitude",
      "query": "Evaluate repurposing opportunities for Sildenafil (small molecule) in High Altitude Pulmonary Edema (pulmonary)",
      "followups": [
        "Analyze unmet medical needs in High Altitude Pulmonary Edema therapy",
        "Assess competitive products and market dynamics for pulmonary conditions",
        "Search clinical trial registries for studies of Sildenafil in High Altitude Pulmonary Edema",
        "Review patent landscape focusing on Sildenafil High Altitude Pulmonary Edema",
        "Evaluate global market size and growth projections for pulmonary conditions",
        "Identify key companies and therapies in pulmonary area",
        "Examine manufacturing and API sourcing considerations for Sildenafil",
        "Monitor recent scientific publications on Sildenafil and high-altitude medicine",
        "Check regulatory status and approvals of Sildenafil in new indication",
        "Draft strategic recommendations for repurposing Sildenafil into High Altitude Pulmonary Edema"
      ]
    },
    {
      "id": "adalimumab_lungfibrosis",
      "query": "Evaluate repurposing opportunities for Adalimumab (biologic) in Idiopathic Pulmonary Fibrosis (pulmonology)",
      "followups": [
        "Analyze unmet medical needs in Idiopathic Pulmonary Fibrosis therapy",
        "Assess competitive products and market dynamics for pulmonology conditions",
        "Search clinical trial registries for studies of Adalimumab in Idiopathic Pulmonary Fibrosis",
        "Review patent landscape focusing on Adalimumab Idiopathic Pulmonary Fibrosis",
        "Evaluate global market size and growth projections for pulmonology conditions",
        "Identify key companies and therapies in autoimmune lung disease area",
        "Examine manufacturing and API sourcing considerations for Adalimumab",
        "Monitor recent scientific publications on Adalimumab and lung fibrosis",
        "Check regulatory status and approvals of Adalimumab in new indication",
        "Draft strategic recommendations for repurposing Adalimumab into Idiopathic Pulmonary Fibrosis"
      ]
    },
    {
      "id": "fluoxetine_neurodegenerative",
      "query": "Evaluate repurposing opportunities for Fluoxetine (small molecule) in Alzheimer's Disease (neurology)",
      "followups": [
        "Analyze unmet medical needs in Alzheimer's Disease therapy",
        "Assess competitive products and market dynamics for neurology conditions",
        "Search clinical trial registries for studies of Fluoxetine in Alzheimer's Disease",
        "Review patent landscape focusing on Fluoxetine Alzheimer's Disease",
        "Evaluate global market size and growth projections for neurology conditions",
        "Identify key companies and therapies in CNS disorders area",
        "Examine manufacturing and API sourcing considerations for Fluoxetine",
        "Monitor recent scientific publications on Fluoxetine and neurodegeneration",
        "Check regulatory status and approvals of Fluoxetine in new indication",
        "Draft strategic recommendations for repurposing Fluoxetine into Alzheimer's Disease"
      ]
    },
    {
      "id": "pembrolizumab_NASH",
      "query": "Evaluate repurposing opportunities for Pembrolizumab (biologic) in Non-Alcoholic Steatohepatitis (hepatology)",
      "followups": [
        "Analyze unmet medical needs in Non-Alcoholic Steatohepatitis therapy",
        "Assess competitive products and market dynamics for hepatology conditions",
        "Search clinical trial registries for studies of Pembrolizumab in Non-Alcoholic Steatohepatitis",
        "Review patent landscape focusing on Pembrolizumab Non-Alcoholic Steatohepatitis",
        "Evaluate global market size and growth projections for hepatology conditions",
        "Identify key companies and therapies in immuno-oncology area",
        "Examine manufacturing and API sourcing considerations for Pembrolizumab",
        "Monitor recent scientific publications on Pembrolizumab and NASH",
        "Check regulatory status and approvals of Pembrolizumab in new indication",
        "Draft strategic recommendations for repurposing Pembrolizumab into Non-Alcoholic Steatohepatitis"
      ]
    },
    {
      "id": "omeprazole_osteoporosis",
      "query": "Evaluate repurposing opportunities for Omeprazole (small molecule) in Osteoporosis (endocrinology)",
      "followups": [
        "Analyze unmet medical needs in Osteoporosis therapy",
        "Assess competitive products and market dynamics for endocrinology conditions",
        "Search clinical trial registries for studies of Omeprazole in Osteoporosis",
        "Review patent landscape focusing on Omeprazole Osteoporosis",
        "Evaluate global market size and growth projections for endocrinology conditions",
        "Identify key companies and therapies in gastroenterology to bone area",
        "Examine manufacturing and API sourcing considerations for Omeprazole",
        "Monitor recent scientific publications on Omeprazole and bone health",
        "Check regulatory status and approvals of Omeprazole in new indication",
        "Draft strategic recommendations for repurposing Omeprazole into Osteoporosis"
      ]
    },
    {
      "id": "rituximab_parkinson",
      "query": "Evaluate repurposing opportunities for Rituximab (biologic) in Parkinson's Disease (neurology)",
      "followups": [
        "Analyze unmet medical needs in Parkinson's Disease therapy",
        "Assess competitive products and market dynamics for neurology conditions",
        "Search clinical trial registries for studies of Rituximab in Parkinson's Disease",
        "Review patent landscape focusing on Rituximab Parkinson's Disease",
        "Evaluate global market size and growth projections for neurology conditions",
        "Identify key companies and therapies in autoimmune neurology area",
        "Examine manufacturing and API sourcing considerations for Rituximab",
        "Monitor recent scientific publications on Rituximab and Parkinson's",
        "Check regulatory status and approvals of Rituximab in new indication",
        "Draft strategic recommendations for repurposing Rituximab into Parkinson's Disease"
      ]
    },
    {
      "id": "ketamine_chronic_pain",
      "query": "Evaluate repurposing opportunities for Ketamine (small molecule) in Chronic Neuropathic Pain (pain)",
      "followups": [
        "Analyze unmet medical needs in Chronic Neuropathic Pain therapy",
        "Assess competitive products and market dynamics for pain management",
        "Search clinical trial registries for studies of Ketamine in Chronic Neuropathic Pain",
        "Review patent landscape focusing on Ketamine Chronic Neuropathic Pain",
        "Evaluate global market size and growth projections for pain therapeutics",
        "Identify key companies and therapies in anesthesia and pain management area",
        "Examine manufacturing and API sourcing considerations for Ketamine",
        "Monitor recent scientific publications on Ketamine and chronic pain",
        "Check regulatory status and approvals of Ketamine in new indication",
        "Draft strategic recommendations for repurposing Ketamine into Chronic Neuropathic Pain"
      ]
    },
    {
      "id": "pioglitazone_alzheimer",
      "query": "Evaluate repurposing opportunities for Pioglitazone (small molecule) in Alzheimer's Disease (neurology)",
      "followups": [
        "Analyze unmet medical needs in Alzheimer's Disease therapy",
        "Assess competitive products and market dynamics for neurology conditions",
        "Search clinical trial registries for studies of Pioglitazone in Alzheimer's Disease",
        "Review patent landscape focusing on Pioglitazone Alzheimer's Disease",
        "Evaluate global market size and growth projections for neurology conditions",
        "Identify key companies and therapies in diabetes to neurodegeneration area",
        "Examine manufacturing and API sourcing considerations for Pioglitazone",
        "Monitor recent scientific publications on Pioglitazone and cognitive decline",
        "Check regulatory status and approvals of Pioglitazone in new indication",
        "Draft strategic recommendations for repurposing Pioglitazone into Alzheimer's Disease"
      ]
    },
    {
      "id": "ivermectin_oncology",
      "query": "Evaluate repurposing opportunities for Ivermectin (small molecule) in Triple Negative Breast Cancer (oncology)",
      "followups": [
        "Analyze unmet medical needs in Triple Negative Breast Cancer therapy",
        "Assess competitive products and market dynamics for oncology conditions",
        "Search clinical trial registries for studies of Ivermectin in Triple Negative Breast Cancer",
        "Review patent landscape focusing on Ivermectin Triple Negative Breast Cancer",
        "Evaluate global market size and growth projections for oncology conditions",
        "Identify key companies and therapies in oncology area",
        "Examine manufacturing and API sourcing considerations for Ivermectin",
        "Monitor recent scientific publications on Ivermectin and cancer",
        "Check regulatory status and approvals of Ivermectin in new indication",
        "Draft strategic recommendations for repurposing Ivermectin into Oncology"
      ]
    }
  ]
}
